Latest filing published 20 Nov 2020 for Allergy Therapeutics Plc, €16k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +115.2%Entry £0.17 · Close at T+365 £0.36
- -32.4%Entry £0.17 · Close at T+365 £0.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Peter Jensen: trading record in brief
All filings by Peter Jensen on record concern Allergy Therapeutics PLC. In total, 2 filings cover trades dated from 23 October 2018 to 19 November 2020.
Every open-market trade on record is a purchase: 2 purchases worth €20k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2020 to date brings 1 purchase and no sales.
Most recently, on 20 November 2020, the filings show an open-market purchase worth €16k in Allergy Therapeutics PLC. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Peter Jensen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares@ £0.14100.0% of flowLondon Stock Exchange - AIMISIN GB00B02LCQ05FCA-NSM:3786734Canonical exit: 17 Feb 2021 (T+90)
- 20,000 shares@ £0.1820.6% of flowLondon Stock Exchange - AIMISIN GB00B02LCQ05FCA-NSM:LSE20181024070003_13839884_20200330111442527_8083-2Canonical exit: 21 Jan 2019 (T+90)
2 of 2 declarations